New Jersey: A Rising Cell & Gene Therapy Hub -- A First Look at BioCentriq™

This historic webinar showcased the next era of cell and gene therapy in New Jersey. BioCentriq™ is a new state-of-the-art cell and gene therapy development center located at the New Jersey Institute of Technology (NJIT). This event was brought to you in partnership by New Jersey Innovation Institute (NJII) and Choose New Jersey. Watch the video to tour this brand new industry-facing contract development and manufacturing organization (CDMO) dedicated to cell and gene therapies. Located in Newark, NJ on the campus of NJIT, BioCentriq™ features GMP suites for clinical production of cell & gene therapies and a process development pilot plant. The center is poised to attract global leaders in the biopharmaceutical industry as well as promising start-ups, which will develop new and innovative therapies.